Literature DB >> 10942317

Interleukin-6-deficient mice refractory to IgA dysregulation but not anorexia induction by vomitoxin (deoxynivalenol) ingestion.

J J Pestka1, H R Zhou.   

Abstract

Dietary exposure to the trichothecene vomitoxin (VT) causes feed refusal and elevates IgA production in the mouse. Based on the observations that IL-6 can cause anorexia and promote IgA production and that gene expression of this cytokine is increased in vivo and ex vivo on VT exposure, we hypothesized that IL-6 is an essential cytokine in VT-induced feed refusal and IgA dysregulation. To test this hypothesis, the effects of dietary VT on feed intake, weight gain, serum IgA levels and kidney mesangial IgA deposition in an IL-6-"knockout" mouse (B6129-IL6(tmi Kopf)) were compared to those in both a corresponding "wildtype" (B6129F2) and a previously characterized "sentinel" strain (B6C3F1) that possess the intact gene for this cytokine. IL-6 deficiency did not alter the capacity of VT to cause feed refusal or impair weight gain. VT-fed B6129F2 and B6C3F1 mice had significantly higher serum IgA concentrations than did their corresponding controls fed clean diet, whereas significant differences were not observed between IL-6 KO mice fed VT or control diets. Kidneys taken from VT-fed wild-type and sentinel mice had significantly increased mesangial IgA deposition as compared to controls. While slight increases in mesangial IgA were observed in VT-fed IL-6 KO mice, mean fluorescence intensities were significantly less than that found in the corresponding wild-type and sentinel strains. IL-6 KO mice appeared to be less prone to the development of microscopic haematuria following VT exposure than were the corresponding wild-type and sentinel strains. In total, the results suggested that IL-6-deficient mice were refractory to VT-induced dysregulation of IgA production and development of IgA nephropathy, whereas chronic VT-mediated nutritional effects related to feed intake and weight gain were unaffected.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942317     DOI: 10.1016/s0278-6915(00)00041-7

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  13 in total

1.  Characterization of deoxynivalenol-induced anorexia using mouse bioassay.

Authors:  Brenna M Flannery; Wenda Wu; James J Pestka
Journal:  Food Chem Toxicol       Date:  2011-05-07       Impact factor: 6.023

Review 2.  IL-6-like cytokines and cancer cachexia: consequences of chronic inflammation.

Authors:  B E Barton
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.

Authors:  James J Pestka
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-03-01       Impact factor: 4.006

Review 4.  Mechanisms of deoxynivalenol-induced gene expression and apoptosis.

Authors:  J J Pestka
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2008-09

5.  Anorexia induction by the trichothecene deoxynivalenol (vomitoxin) is mediated by the release of the gut satiety hormone peptide YY.

Authors:  Brenna M Flannery; Erica S Clark; James J Pestka
Journal:  Toxicol Sci       Date:  2012-08-17       Impact factor: 4.849

6.  Deoxynivalenol and its toxicity.

Authors:  Pavlina Sobrova; Vojtech Adam; Anna Vasatkova; Miroslava Beklova; Ladislav Zeman; Rene Kizek
Journal:  Interdiscip Toxicol       Date:  2010-09

7.  Mechanisms for suppression of interleukin-6 expression in peritoneal macrophages from docosahexaenoic acid-fed mice.

Authors:  Yuhui Shi; James J Pestka
Journal:  J Nutr Biochem       Date:  2008-07-07       Impact factor: 6.048

8.  Role of GRP78/BiP degradation and ER stress in deoxynivalenol-induced interleukin-6 upregulation in the macrophage.

Authors:  Yuhui Shi; Katie Porter; Narayanan Parameswaran; Hee Kyong Bae; James J Pestka
Journal:  Toxicol Sci       Date:  2009-03-31       Impact factor: 4.849

Review 9.  Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae.

Authors:  James J Pestka
Journal:  Toxins (Basel)       Date:  2010-06-01       Impact factor: 4.546

Review 10.  Advances in deoxynivalenol toxicity mechanisms: the brain as a target.

Authors:  Marion S Bonnet; Julien Roux; Lourdes Mounien; Michel Dallaporta; Jean-Denis Troadec
Journal:  Toxins (Basel)       Date:  2012-11-01       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.